Investigational Compound BI 1815368 Builds on Phase I Data
In 2024, the safety, tolerability, pharmacokinetics, and pharmacodynamics of BI 1815368 were evaluated in 26 healthy male patients in Japan in a Phase I trial (NCT06494774).3 An additional Phase I trial (NCT06655220) assessed whether taking BI 1815368 along with metformin affects the amount of metformin in the bloodstream, compared to when metformin is taken as a monotherapy.4
Addressing a Leading Cause of Vision Loss in Diabetes
According to Roche, approximately 750,000 people in the United States are currently living with DME. It is a leading cause of vision loss among the working-age populations of most developed countries. The risk of developing the condition increases as the severity of diabetic retinopathy increases, although it can occur at any stage.5
Boehringer’s Long-Term Vision for Eye Health Innovation
“At Boehringer Ingelheim, we are working towards a future where earlier intervention leads to long-term outcomes that prevent vision loss,” said Patrick Bussfeld, global head, medicine, eye health, Boehringer Ingelheim, in the press release.“One way we aim to achieve this is by developing oral treatments, which offer patients the ability to be more in control of their condition. By targeting the disease pathway systemically, we also have the potential to prevent DME in one eye while the other is being treated.”
References
Boehringer Ingelheim initiates Phase II study of BI 1815368, a potential first-in-class oral treatment for diabetic macular edema. Boehringer Ingelheim. July 7, 2025. Accessed July 7, 2025. https://www.boehringer-ingelheim.com/science-innovation/human-health-innovation/phase-ii-start-oral-treatment-diabetic-macular-edema
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema. Clinicaltrials.gov. Accessed July 7, 2025. https://clinicaltrials.gov/study/NCT06962839
A Study to Test How Different Doses of BI 1815368 Are Tolerated and How BI 1815368 is Taken up in the Body of Healthy Japanese Men. Clinicaltrials.gov. Accessed July 7, 2025. https://clinicaltrials.gov/study/NCT06494774?term=NCT06494774&rank=1
A Study in Healthy Men to Test Whether BI 1815368 Influences the Amount of Metformin in the Body. Clinicaltrials.gov. Accessed July 7, 2025. https://clinicaltrials.gov/study/NCT06655220?term=NCT06655220&rank=1
Diabetic Macular Edema (DME) Fact Sheet. Genentech. Accessed July 7, 2025. https://www.gene.com/patients/disease-education/diabetic-macular-edema